DNL-952

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameDNL-952
Drug Alias NameETV-GAAETV:GAADNL-952
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionAlpha glucosidase replacements
TargetsGlycogen
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A